Eduard Sergienko

发表

Figure 3, Profiling of the 21 most active VHR screening hits at 20 µM against VHR (AID-2074) & HePTP (AID-2082)

Stefan Vasile, Ying Su, Thomas D.Y. Chung, 2010 .

Figure 1, [Comparative data on (1) probe, (2) similar compound structures (establishing SAR) and (3) prior probes].

Ying Su, Thomas D.Y. Chung, Derek Stonich, 2010 .

Table 5, Submission information on Probe 2 and analogs

Ying Su, Thomas D.Y. Chung, Derek Stonich, 2010 .

Figure 2, Probe analogs variations: 3 regions were explored by chemical synthesis: the left hand side (LHS), linker and right hand side (RHS)

Ying Su, Thomas D.Y. Chung, Derek Stonich, 2010 .

Figure 1, Summary of the hit structures for the KOP antagonist project

Susanne Heynen-Genel, Thomas D.Y. Chung, Palak Gosalia, 2010 .

Figure 3, Flowchart Summary of Screening Results

Stefan Vasile, Eigo Suyama, Ying Su, 2011 .

Selective Bcl-2 Inhibitor Probes

Tudor I. Oprea, Bruce S. Edwards, Larry A. Sklar, 2013 .

Spectroscopic evidence for participation of the 1',4'-imino tautomer of thiamin diphosphate in catalysis by yeast pyruvate decarboxylase.

Frank Jordan, Eduard Sergienko, Zhen Zhang, 2002, Bioorganic chemistry.

Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro.

Stefan Vasile, Eigo Suyama, Michael Vicchiarelli, 2012, Journal of medicinal chemistry.